All patients in our cohort had ≥50% stainable tumor cells (according to the EORTC-STBSG), which could explain why preoperative therapy did not significantly affect TEM-1, PDGFR-α, and VEGF-A expression [28]. The gene discussed is CD248; the disease is neoplasm.